Publications by authors named "Masahiro Fukuoka"

100Publications

False-Positive Elevation of CK-MB Levels with Chest Pain in Lung Adenocarcinoma.

Case Rep Oncol 2020 Jan-Apr;13(1):100-104. Epub 2020 Feb 11.

Department of Medical Oncology, Izumi City General Hospital, Izumi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000505724DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098329PMC
February 2020

Porous diaphragm syndrome with recurrent thymoma.

Respirol Case Rep 2019 Feb 28;7(2):e00391. Epub 2018 Nov 28.

Department of Medical Oncology Izumi City General Hospital Izumi Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rcr2.391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261833PMC
February 2019

The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer.

J Thorac Oncol 2018 06 23;13(6):792-800. Epub 2018 Mar 23.

Graduate Institute of Oncology, National Taiwan University and Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.010DOI Listing
June 2018

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Lung Cancer 2018 03 9;117:14-19. Epub 2018 Jan 9.

Department of Medical Oncology, Izumi Municipal Hospital, 4-10-10 Fuchu, Izumi, 594-0071, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.01.005DOI Listing
March 2018

Use of hormone therapies in disseminated carcinomatosis of the bone marrow associated with hormone receptor-positive breast cancer.

Gynecol Endocrinol 2018 Apr 26;34(4):286-289. Epub 2017 Oct 26.

a Department of Medical Oncology , Izumi Municipal Hospital , Izumi , Osaka , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590.2017.1393063DOI Listing
April 2018

Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.

Immunotherapy 2017 08 26;9(9):701-707. Epub 2017 Jun 26.

Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0043DOI Listing
August 2017

Abdominal pain under immunosuppressive conditions.

Cleve Clin J Med 2016 Dec;83(12):874-875

Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.83a.15143DOI Listing
December 2016

Drug-induced Pneumonitis Following the Administration of TAS-102.

Intern Med 2016;55(19):2855-2859. Epub 2016 Oct 1.

Department of Medical Oncology, Izumi Municipal Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.55.6629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088549PMC
February 2017

Catheter detachment.

Oxf Med Case Reports 2015 May 19;2015(5):292-3. Epub 2015 May 19.

Department of Medical Oncology , Izumi Municipal Hospital , Izumi, Osaka , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/omcr/omv038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617418PMC
May 2015

Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer.

Lung Cancer 2014 Nov 28;86(2):201-6. Epub 2014 Sep 28.

Izumi Municipal Hospital, 4-10-10 Fuchu-cho, Izumi-shi, Osaka 594-0071, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.09.015DOI Listing
November 2014

Erlotinib is a well-tolerated alternate treatment for non-small cell lung cancer in cases of gefitinib-induced hepatotoxicity.

Anticancer Res 2014 Sep;34(9):5211-5

Izumi Municipal Hospital, Department of Medical Oncology, Izumi, Osaka, Japan.

View Article

Download full-text PDF

Source
September 2014

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS).

Lung Cancer 2014 Feb 1;83(2):174-81. Epub 2013 Dec 1.

State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002130053
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2013.11.021DOI Listing
February 2014

A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2013 Nov 18;72(5):1063-71. Epub 2013 Sep 18.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2277-8DOI Listing
November 2013

A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.

Invest New Drugs 2013 Dec 24;31(6):1568-72. Epub 2013 Aug 24.

Division of thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10637-013-0014
Web Search
http://link.springer.com/10.1007/s10637-013-0014-0
Publisher Site
http://dx.doi.org/10.1007/s10637-013-0014-0DOI Listing
December 2013

Early palliative intervention for patients with advanced cancer.

Jpn J Clin Oncol 2013 Aug 4;43(8):788-94. Epub 2013 Jun 4.

Department of Palliative Care, Sakai Hospital, Kinki University Faculty of Medicine, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt074DOI Listing
August 2013

Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways.

J Am Heart Assoc 2013 Apr 22;2(2):e000191. Epub 2013 Apr 22.

Division of Cardiology, Heart and Stroke/Richard Lewar Centre of Excellence, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.113.000191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647266PMC
April 2013

Post-marketing surveillance (PMS) of all patients treated with irinotecan in Japan: clinical experience and ADR profile of 13,935 patients.

Jpn J Clin Oncol 2011 Sep 17;41(9):1101-11. Epub 2011 Aug 17.

Yakult Honsha Co., Ltd., 4F Ginza-Kobiki Bldg., 16-21, Ginza 7-Chome, Chuo-ku, Tokyo 104-0061, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr105DOI Listing
September 2011

The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations.

Ther Adv Med Oncol 2010 Sep;2(5):301-7

Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834010370698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126025PMC
September 2010

Cathepsin-L contributes to cardiac repair and remodelling post-infarction.

Cardiovasc Res 2011 Feb 8;89(2):374-83. Epub 2010 Dec 8.

Division of Cardiology, Heart and Stroke/Richard Lewar Centre of Excellence, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cvr/cvq328DOI Listing
February 2011

Lung cancer working group report.

Jpn J Clin Oncol 2010 Sep;40 Suppl 1:i7-12

Medical Oncology Division, Kinki University School of Medicine, 377-2 Ono-Higashi, Osaka-Sayama City, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq121DOI Listing
September 2010

Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type.

Anticancer Res 2010 Jul;30(7):2985-90

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
July 2010

Successful treatment with erlotinib after gefitinib-induced severe interstitial lung disease.

J Thorac Oncol 2010 Jul;5(7):1103-4

Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181d89ac2DOI Listing
July 2010

Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.

Circulation 2010 Jun 7;121(24):2624-34. Epub 2010 Jun 7.

Division of Cardiology, Heart and Stroke/Richard Lewar Centre of Excellence, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.109.8
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.893248DOI Listing
June 2010

A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).

Jpn J Clin Oncol 2010 Oct 3;40(10):992-4. Epub 2010 Jun 3.

Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyq079DOI Listing
October 2010

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer.

Cancer Chemother Pharmacol 2011 Mar 15;67(3):533-42. Epub 2010 May 15.

Department of Respiratory Medicine, Kitasato University School of Medicine, Minami-ku, Kitasato, Sagamihara, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1340-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043260PMC
March 2011

Disease control as a predictor of survival with gefitinib and docetaxel in a phase III study (V-15-32) in advanced non-small cell lung cancer patients.

J Thorac Oncol 2010 Jul;5(7):1042-7

Department of Thoracic Diseases, Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181da36dbDOI Listing
July 2010

Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification.

Mol Cancer Ther 2010 May 27;9(5):1198-207. Epub 2010 Apr 27.

Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0045DOI Listing
May 2010

Successful treatment with erlotinib after gefitinib-related severe hepatotoxicity.

J Clin Oncol 2010 Jun 12;28(17):e273-4. Epub 2010 Apr 12.

Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.5496DOI Listing
June 2010

Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.

Anticancer Res 2010 Feb;30(2):557-63

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
February 2010

[Internal medicine specially addressed to oncology: its role in tumor care].

Authors:
Masahiro Fukuoka

Nihon Naika Gakkai Zasshi 2009 Aug;98(8):1837-40

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/naika.98.1837DOI Listing
August 2009

Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.

Jpn J Clin Oncol 2010 Jan 16;40(1):54-9. Epub 2009 Oct 16.

Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyp137DOI Listing
January 2010

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

N Engl J Med 2009 Sep 19;361(10):947-57. Epub 2009 Aug 19.

State Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa0810699DOI Listing
September 2009

Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non-small cell lung cancer cells.

Clin Cancer Res 2009 Aug 11;15(16):5117-25. Epub 2009 Aug 11.

Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0478DOI Listing
August 2009

Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.

Cancer Res 2009 Aug 28;69(16):6515-21. Epub 2009 Jul 28.

Department of Medical Oncology, Kinki University School of Medicine, Sakai Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1076DOI Listing
August 2009

S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer.

Clin Lung Cancer 2009 Jul;10(4):290-4

Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.n.040DOI Listing
July 2009

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumors.

Cancer Chemother Pharmacol 2010 Jan;65(2):243-50

Department of Medical Oncology, Kinki University School of Medicine, Ohno-higashi, Osaka-Sayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1028-3DOI Listing
January 2010

Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.

Eur J Cancer 2009 Aug 4;45(12):2132-7. Epub 2009 May 4.

Outpatients Treatment Center, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.04.003DOI Listing
August 2009

A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.

Jpn J Clin Oncol 2009 Jul 24;39(7):425-30. Epub 2009 Apr 24.

Division of Thoracic Oncology, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyp038DOI Listing
July 2009

A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial.

J Thorac Oncol 2009 May;4(5):644-8

Department of Medical Oncology, Kinki University, School of Medicine, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31819f978aDOI Listing
May 2009

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks.

Cancer Sci 2009 Feb;100(2):316-21

1TZT-1027 Cooperative Study Group, and Division of Thoracic Oncology, Shizuoka Cancer Center, Shimonagakubo 1007 Shunto-gun, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2008.01023.xDOI Listing
February 2009